KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent

BACKGROUND: KRAS, although a common variant of occurrence (~20% of non‐small‐cell lung carcinoma [NSCLC]) has been untargetable, owing to the molecular structure which inherently prevents drug binding. KRAS mutations in NSCLC are associated with distinct clinical profiles including smokers and mucin...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Ullas, Nathany, Shrinidhi, Sharma, Mansi, BP, Amrith, Jose, Joslia T., Singh, Harkirat, Mattoo, Sakshi, Mehta, Anurag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939094/
https://www.ncbi.nlm.nih.gov/pubmed/36069080
http://dx.doi.org/10.1002/cam4.5193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939094/
https://www.ncbi.nlm.nih.gov/pubmed/36069080
http://dx.doi.org/10.1002/cam4.5193

Ejemplares similares